DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1BELRAPZO
02 1BENDEKA
03 1CYCLOPHOSPHAMIDE
04 1DEFINITY
05 1DEFINITY RT
06 1INFUVITE ADULT
07 1ISTODAX
08 1M.V.I. ADULT
09 3PARICALCITOL
10 2REGADENOSON
11 1TEMSIROLIMUS
01 221064
02 121163
03 121625
04 122393
05 1201657
06 1203153
07 1203897
08 1205580
09 1207692
10 1208194
11 1212501
12 1213856
13 1217455
01 9No
02 5Yes
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : CYCLOPHOSPHAMIDE
Dosage Form : SOLUTION; INTRAVENOUS
Application Number : 212501
Country : US
Patented : Yes
Drug : TEMSIROLIMUS
Dosage Form : SOLUTION; INTRAVENOUS
Application Number : 203153
Country : US
Patented : No
Drug : REGADENOSON
Dosage Form : SOLUTION; INTRAVENOUS
Application Number : 217455
Country : US
Patented : No
Drug : ISTODAX
Dosage Form : POWDER; INTRAVENOUS
Application Number : 22393
Country : US
Patented : No
Drug : BENDEKA
Dosage Form : SOLUTION; INTRAVENOUS
Application Number : 208194
Country : US
Patented : Yes
Drug : BELRAPZO
Dosage Form : SOLUTION; INTRAVENOUS
Application Number : 205580
Country : US
Patented : Yes
Drug : PARICALCITOL
Dosage Form : SOLUTION; INTRAVENOUS
Application Number : 207692
Country : US
Patented : No
Drug : DEFINITY RT
Dosage Form : INJECTABLE; INTRAVENOUS
Application Number : 21064
Country : US
Patented : Yes
Drug : DEFINITY
Dosage Form : INJECTABLE; INTRAVENOUS
Application Number : 21064
Country : US
Patented : Yes
Drug : PARICALCITOL
Dosage Form : SOLUTION; INTRAVENOUS
Application Number : 203897
Country : US
Patented : No
